Annexon Biosciences

Contributing Author

Recent Articles by Annexon Biosciences

Jun-18	Annexon Bolsters Ophthalmology Expertise with Appointment of Retina Specialist Lloyd Clark, M.D., as Pivotal ANX007 Program Advances in Dry Age-Related Macular Degeneration (AMD) with Geographic Atrophy (GA) ANNX GlobeNewswire
May-29	Annexon Biosciences to Present at the Jefferies Global Healthcare Conference ANNX GlobeNewswire
May-19	Annexon Showcases Tanruprubart Data Demonstrating Improved Clinical Outcomes in Guillain-Barre Syndrome (GBS) at 2025 Peripheral Nerve Society (PNS) Annual Meeting ANNX GlobeNewswire
May-16	Annexon Reports Inducement Grants to New Employees Under Nasdaq Listing Rule 5635(c)(4) ANNX GlobeNewswire
May-12	Annexon Reports First Quarter 2025 Financial Results, Portfolio Progress and Key Anticipated Milestones ANNX GlobeNewswire
May-09	Annexon Announces Presentations on the Clinical Advancement of Tanruprubart as the First Potential Targeted Therapy for Guillain-Barre Syndrome (GBS) at the 2025 PNS Meeting ANNX GlobeNewswire
May-07	Annexon to Present on the Neuroprotective Effects of ANX007 at the 2025 ARVO Annual Meeting and the Retina World Congress ANNX GlobeNewswire